Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Type, End-User & Application The global neurovascular devices market will witness a robust CAGR of 8.6%, valued at $2.82 Billion in 2021, expected to appreciate and reach $5.92 Billion by 2030, confirms Strategic Market Research. Neurovascular devices, also called interventional neurology devices, include neurovascular stents, clips, neurovascular coils, distal filter devices, cerus contour devices and carotid artery stents used to treat neurovascular disorders such as ischemic stroke aneurysm, arteriovenous malformation and fistulas, and stenosis. These mainly refer to the non-surgical speciality, which uses minimally invasive, image-guided techniques to treat hazardous and complex diseases of the brain, neck, and spine. As per the International Hemorrhagic Stroke Association January 2020, at least 36 percent of hospitalized COVID-19 patients exhibited neurological symptoms, and several cases reported were related to ischemic & hemorrhagic infarction. The rise in R&D investments and expansion in the geriatric population with the increase in neurological diseases are the primary drivers of the market's growth, with North America dominating the regional market share in 2020. Market Dynamics Market Drivers – Increase in the investments in Research and Development due to the rise in the neurological diseases An increase in the number of diseases related to neurological disorders such as brain/ cerebral aneurysm, strokes, and epilepsy, among many others, in several countries, is expected to drive the market growth and hence is a significant driver for the market. As per the NHS (National Health Service) England, around 1 in 12,500 people in England have a ruptured brain aneurysm every year, and about 3% of the adults in the UK have a cerebral aneurysm which is due to the increase in the prevalence of hypertension, alcohol consumption and smoking that resulted in a brain aneurysm. The increase in the geriatric population suffering from ischemic stroke and other neurological disorders is one of the significant neurovascular devices market drivers. According to CDC (Centres for disease control and prevention), about 87% of strokes are ischemic strokes in which the flow of blood to the brain is blocked, and the brain cells die, which results in a loss of neurological function, especially in the aged people with the US being the most affected country. With the rise in the number of patients and the fatality rate in the target patients, the demand for neurovascular devices has increased across various markets worldwide. According to the NCBI, strokes occur more commonly in women than men, especially in the elderly population aged 55 between 65. Restraints – High cost for the treatment of neurosurgical procedures The high cost of treating neurovascular diseases and maintenance costs, and other indirect expenses limit the adoption of neurovascular devices in small hospitals. Due to the less scope for reimbursement, only limited patients can afford the treatment of neurological disorders. Opportunities – Increase in the demand for the modern and affordable methods to treat age-old patients As per the study published at JAMA Network Open Journal, all Robot-assisted surgeries have considerably accounted an overall share of 15.1% in terms of all general surgeries in the year 2018. Moreover, according to the NCBI, on a global basis, approximately 310 Mn of the key major surgeries are performed on a annual basis; including 40 to 50 Mn in USA and 20 Mn in Europe. Hence, due to this increase in the demand for minimalistic surgical procedures and post-surgery methods like shorter stay at the hospital, affordability, and faster recovery of patients has increased the acceptance, which plays a crucial role in the future growth of the neurovascular devices among the medical professionals and the patients. The innovative technologies will continue to widen the range of neurovascular tools available for treating different aneurysm types with greater safety and efficiency, and the aneurysm management is constantly evolving, with sophisticated technology at the forefront of innovation. As per the Southwestern Medical Center, about 795,000 people in the US suffer from a stroke every year. The increase in the efficacy of the tools invented will reduce the mortality rate affected by the stroke. Global Neurovascular Devices Market Analysis of different Segmentations The Global Neurovascular Market segmentation is performed based on Product, Application, End-User, and Region. Based on Type Embolization Stenting systems Support Devices Neurovascular Microcatheters Neurovascular Guidewires Neurovascular thrombectomy devices Based on Application Carotid Artery Stenosis Cerebral Aneurysm Arteriovenous Malformations and Fistulas Ischemic Strokes Based on End-User Hospitals Speciality care centres Ambulatory centres Research laboratories Academic institutions Based on Region North America US Mexico Canada Rest of North America Europe Switzerland France Germany U.K Russia Finland Turkey Belgium Italy Spain Netherlands Rest of Europe Asia Pacific India China South Korea Japan Indonesia Thailand Malaysia Singapore Philippines Australia New Zealand Rest of Asia Pacific LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Based on the Type, the Embolization segment dominated the overall market with a share of 38 percent, along with a focus on new and cost-effective systems. It is attributed to embolic neurovascular coils, which are efficient with reliable clinical data showing dominance over surgical clipping procedures. As per the CDC, 1 in 6 people worldwide will have a stroke once in their lifetime, and more than 795,000 people in the United States have a stroke each year. Rising healthcare expenditure, Increasing prevalence of neurological conditions such as brain aneurysms, stroke, arteriovenous malformations (AVMs), and increasing R&D investment drive the market growth. Based on the Application, the Cerebral Aneurysm segment dominated the overall neurovascular devices market with a steady CAGR during the forecasted period due to the availability of the new device for the treatment of the condition, which helps fuel the demand for the neurovascular devices. As per the Brain Aneurysm Foundation report, approximately 6.5 million people in the US have an unruptured brain aneurysm. Almost 30,000 people suffer a brain aneurysm rupture each year, which ruptures every 18 minutes. Based on End Users, the hospital segment dominated the overall market share during the forecasted period due to the higher adoption rate of neurovascular devices in most hospitals due to the increase in the patients suffering from neurological conditions. Based on Region, North America accounts for the dominant market share of about 26.8% in 2020 due to some major manufacturers and an increase in neurological diseases. According to the Brain Aneurysm Foundation, cerebral aneurysms have affected 6 million Americans. They are accountable for nearly half a million deaths worldwide, with half the victims aged 50 years and younger every year. Asia is growing at a CAGR of 7.9% during the estimated period. As per the Journal published at NCBI, the overall occurrence rates of the spectrum of neurological disorders from various regions of the country had ranged from 967-4,070 with a mean of 2394 per 100,000 population, thereby providing a rough estimation of over 30 Mn people with neurological disorders. This is due to the rising target disease burden, rising healthcare expenditure, and entry of key players contributing to the market growth. Neurovascular Devices Market Report Coverage Report Attribute Details Forecast Period 2021-2030 Market size value in 2021 USD 2.82 billion Revenue forecast in 2030 USD 5.92 Billion Growth rate CAGR of approximately 8.6% Base year for estimation 2021 Historical data 2017-2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Technology, By End User, and By Region. By Product Embolization, Stenting systems, Support Devices, And Neurovascular thrombectomy devices By Application Carotid Artery Stenosis, Cerebral Aneurysm, Arteriovenous Malformations and Fistulas, Ischemic Strokes By End-User Hospitals, Specialty care centers, Ambulatory centers, Research laboratories and Academic institutions By Region North America, Europe, Asia Pacific and LAMEA Country Scope U.S. , Canada , France, Germany ,U.K. , China , Japan, India , South Korea, Mexico, Brazil , UAE etc. Company Usability Profiles Stryker, Medtronic plc,Johnson & Johnson Services ,Penumbra. Inc , Micro Port Scientific Corporation ,Terumo Corporation, WL. Gore & Associated Inc. and Merit Medical Systems. Global Neurovascular Devices Market Competitive Landscape Analysis The competitive landscape analysis provides information about the significant competitors prevailing in the global market environment. Based on a vast distribution network and a diversified and robust portfolio, the comparison of various players is performed. The key players that are included in the Global Neurovascular medical device Market report are: Stryker Medtronic plc Johnson & Johnson Services Penumbra. Inc Micro Port Scientific Corporation Terumo Corporation WL. Gore & Associated Inc. Merit Medical Systems Others Recent Developments In January 2021, Penumbra and Genesis MedTech Group announced a collaboration to expand the neurovascular market in China and also acquired Hua Med Tech to form a franchise. As per the industry reports, the scale of China's neurovascular market is estimated to be more than USD $1 billion and is expected to reach USD $2 billion by 2023, which propels China to become the world's second-largest neurovascular market. In 2020, Johnson & Johnson launched a suite of 3 devices, which include the Cerenovus Large Bore Catheter, Cerebase DA Guide Sheath, and Embotrap III Revascularization Device, to help the physicians in procedures like clot removals which can shape the future of health and benefit even more people around the world. On February, 2020, NeuroVasc Technologies, Inc. entered into a strategic partnership with the Wego Group with funding of USD $34 million to support the company’s product development and clinical trial program with a focus on treating neurovascular disease based on novel catheter-based technologies. In July 2020, Rapid Medical, an Israel based company, was granted European regulatory clearance to launch and commercialize its ‘TIGERTRIEVER XL device for is the first-ever adjustable and fully visible clot retriever designed to treat ischemic stroke, which can reduce the number of passes required to remove large stroke-causing clots, for example, in the internal carotid artery. On October, 2020, Bendit Technologies, an Israel-based medical device company, submitted the successful results of the first-in-human use of the Bendit steerable neuro microcatheter at Sheba Medical Center in Tel Aviv, Israel, received FDA and CE Mark approval for peripheral use and advised that it will submit the Bendit microcatheter for the neurovascular indication in the near future. A team of doctors at the Sheba Medical Center’s Neuro-Interventional & Stroke Center performed the life-saving neuro-interventional procedure on a man of74 years with a massive brain aneurysm using the Bendit steerable device and ended up with very successful results Various leading Neurovascular Devices that key market leaders develop Name of the product Function Key Players Catheters Interventions in the brain and intracranial spaces to perform neurovascular surgeries Stryker, Medtronic, and Penumbra, Inc. Neurovascular embolization coils Treatment of brain aneurysms and other abnormalities. Medtronic plc, Stryker Corporation, Terumo Corporation., Johnson & Johnson Services, Inc., Penumbra Inc. Neurovascular Guide Wires To deliver therapeutic devices to either clots or aneurysms in the arteries in the brain. MicroVention, Phenox, Shanghai Kindly Medical Instruments, Shenzhen MicroApproach Medical Technology Neurovascular stent Treat brain aneurysms without the need for surgery Meko Frequently Asked Question About This Report What are neurovascular catheters? Neurovascular catheters are the devices used for the interventions in the brain to perform neurovascular surgeries as the organs are susceptible to vessel damage, and the neurovascular catheters market in 2020 was USD 626.60 million. What are the critical drivers of market? The key drivers include an increase in investments in research and development due to the rise in neurological diseases. What are the key players in the market? The key players included in the global market report are Stryker, Medtronic plc, Johnson & Johnson Services, and Penumbra. Inc, Micro Port Scientific Corporation, Terumo Corporation, W.L. Gore & Associated Inc. and Merit Medical Systems. How big is this neurovascular devices market size? The global neurovascular devices market size was $2.82 bn in 2021 and is predicted to reach $5.92 bn by 2030, representing a CAGR of 8.6%. What is the neurovascular devices market growth? The global neurovascular devices market is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2030 to reach USD 5.92 Billion by 2030. Sources https://www.cdc.gov/stroke/facts.htm https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665267/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388795 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Neurovascular Devices Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Analysis 4.3.1 Global Market, by region, 2021 - 2030 (USD Million) 4.4 By Type Analysis 4.4.1 Global Market, By Type, 2021 - 2030 (USD Million) 4.5 By End-User Analysis 4.5.1 Global Market, By End-User, 2021 - 2030 (USD Million) 4.6 Application Analysis 4.6.1 Global Market, By Application, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Neurovascular Devices Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Embolization 7.3.1. Embolization market, 2021 - 2030 (USD Million) 7.4. Stenting systems 7.4.1. Stenting systems market, 2021 - 2030 (USD Million) 7.5. Support Devices 7.5.1. Support Devices market, 2021 - 2030 (USD Million) 7.5.1.1 Neurovascular Microcatheters market, 2021 - 2030 (USD Million) 7.5.1.2 Neurovascular Guidewires market, 2021 - 2030 (USD Million) 7.7. Neurovascular thrombectomy devices 7.7.1. Neurovascular thrombectomy devices market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021 - 2030 (USD Million) 8.4. Specialty care centres 8.4.1. Specialty care centres market, 2021 - 2030 (USD Million) 8.5. Ambulatory centres 8.5.1. Ambulatory centres market, 2021 - 2030 (USD Million) 8.6. Research laboratories 8.6.1. Research laboratories market, 2021 - 2030 (USD Million) 8.7. Academic institutions 8.7.1. Academic institutions market, 2021 - 2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Carotid Artery Stenosis 9.3.1. Carotid Artery Stenosismarket, 2021 - 2030 (USD Million) 9.4. Cerebral Aneurysm 9.4.1. Cerebral Aneurysmmarket, 2021 - 2030 (USD Million) 9.5. Arteriovenous Malformations and Fistulas 9.5.1. Arteriovenous Malformations and Fistulasmarket, 2021 - 2030 (USD Million) 9.6. Ischemic Strokes 9.6.1. Ischemic Strokesmarket, 2021 - 2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America Market, by By Type, 2021 - 2030 (USD Million) 10.1.2. North America Market, by By End-User, 2021 - 2030 (USD Million) 10.1.3. North America Market, by Application, 2021 - 2030 (USD Million) 10.1.4. North America Market, by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, by By Type, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, by By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, by Application, 2021 - 2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada Market, by By Type, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, by By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, by Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, by By Type, 2021 - 2030 (USD Million) 10.2.2. Europe Market, by By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe Market, by Application, 2021 - 2030 (USD Million) 10.2.4. Europe Market, by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, by By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, by Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, by By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, by Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, by By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, by By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, by By Type, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, by By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, by By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, by By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. IndiaMarket, by Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. JapanMarket, by By Type, 2021 - 2030 (USD Million) 10.3.4.3.2. JapanMarket, by By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, by By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFICMarket, by By Type, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFICMarket, by By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFICMarket, by Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, by By Type, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, by By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, by By Type, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, by By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, by By Type, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, by By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America Market, by By Type, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, by By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, by By Type, 2021 - 2030 (USD Million) 10.5.2. MEA Market, by By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA Market, by Application, 2021 - 2030 (USD Million) 10.5.4. MEA Market, by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Stryker 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. MEDTRONIC PLC 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. JOHNSON & JOHNSON SERVICES 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. PENUMBRA. INC 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. MICRO PORT SCIENTIFIC CORPORATION 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Terumo Corporation 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. W.L. Gore & Associated Inc. 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Merit Medical Systems 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development List of Tables (53 Tables) TABLE 1. Market, By Type, 2021-2030 (USD Million) TABLE 2. Market FOR Embolization, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Stenting systems, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Support Devices, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Neurovascular Microcatheters, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Neurovascular Guidewires, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Neurovascular thrombectomy devices, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, By End-User, 2021-2030 (USD Million) TABLE 9. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Specialty care centres, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Ambulatory centres, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Research laboratories, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Academic institutions, BY REGION, 2021-2030 (USD Million) TABLE 14. Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 15. Market FOR Carotid Artery Stenosis, BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Cerebral Aneurysm, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Arteriovenous Malformations and Fistulas, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Ischemic Strokes, BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 20. Market, BY REGION, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA Market, By Type, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 25. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. EUROPE Market, By Type, 2021-2030 (USD Million) TABLE 27. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 28. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC Market, By Type, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 34. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. LAMEA Market, By Type, 2021-2030 (USD Million) TABLE 36. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 37. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 38. Stryker: COMPANY SNAPSHOT TABLE 39. Stryker: OPERATING SEGMENTS TABLE 40. MEDTRONIC PLC: COMPANY SNAPSHOT TABLE 41. MEDTRONIC PLC: OPERATING SEGMENTS TABLE 42. JOHNSON & JOHNSON SERVICES: COMPANY SNAPSHOT TABLE 43. JOHNSON & JOHNSON SERVICES: OPERATING SEGMENTS TABLE 44. PENUMBRA. INC : COMPANY SNAPSHOT TABLE 45. PENUMBRA. INC : OPERATING SEGMENTS TABLE 46. MICRO PORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT TABLE 47. MICRO PORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS TABLE 48. Terumo Corporation: COMPANY SNAPSHOT TABLE 49. Terumo Corporation: OPERATING SEGMENTS TABLE 50. W.L. Gore & Associated Inc.: COMPANY SNAPSHOT TABLE 51. W.L. Gore & Associated Inc.: OPERATING SEGMENTS TABLE 52. Merit Medical Systems: COMPANY SNAPSHOT TABLE 53. Merit Medical Systems: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 5 Market: Product-Based Estimation Figure 6 Top 8 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Neurovascular Devices, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Neurovascular Devices, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Embolization to Witness Higher CAGR in Market for Type Segment during Forecast Period. Figure 16 Cerebral Aneurysm to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview